Current stock page

Catalysts

GMRE Stock Catalysts

Earnings · Growth Drivers · Events · AIQ Catalyst

Real EstateREIT - Healthcare FacilitiesScore data as of Sep 7, 2026

GMRE

Catalysts
Global Medical REIT Inc.
Real Estate· REIT - Healthcare Facilities
AIQ Score
NeutralAIQ Edge 6/10
Low Priority
Above Peers
Score data as of Sep 7, 2026
Last price
Latest market quote
Momentum
Value60
Quality26
Risk Resilience78
Sentiment
View financial data

Stock Catalyst Board

Earnings timing, analyst expectations, news pressure, growth drivers, events, and AIQ Catalyst context.

Next earnings

No upcoming reporting date is available yet.

AIQ Catalyst
AIQ 50/100

Momentum and sentiment before the next covered event.

Recent coverage
1 articles

Updated Sep 6, 2026 · Sentiment 24.45%

Earnings History And Surprises

See whether reported EPS and revenue have consistently exceeded or missed analyst expectations.

Earnings Expectations And Results

Compare what analysts expected with what the company reported across recent quarters.

Momentum AIQ Edge 6/10 Above Peers
Beat rate
63%
5 of 8 reported periods
Average surprise
+952.0%
Across covered historical reports
Latest result
+1592.3%
Feb 25, 2026
EPS estimate versus actual
Actual bars are colored by beat, inline result, or miss.
Earnings history
Report dateFiscal periodEPS estimateEPS actualEPS surpriseRevenue estimateRevenue actual
Feb 25, 2026$0.07$1.10+1592.3%$37.44M$35.17M
Nov 4, 2025$0.16-$0.45-381.3%$38.19M$37.04M
Aug 5, 2025$0.03-$0.05-250.0%$35.34M$37.88M
May 7, 2025$0.05$0.79+1480.0%$35.19M$34.6M
Feb 27, 2025$0.01$0.52+5100.0%$34.46M$34.95M
Nov 6, 2024$0.08$0.15+100.0%$34.72M$34.18M
Aug 6, 2024$0.20-$0.05-125.0%$34.38M$34.21M
May 8, 2024$0.03$0.05+100.0%$33.89M$35.07M

Analyst Forecast And Price Targets

Wall Street consensus, rating distribution, and the current 12-month target range.

Analyst ratings
Buy
5
Buy
4
Hold
12-month analyst target
$40.00
versus current price
Based on 1 analyst observations. Targets are estimates, not predictions.
Low target
$40.00
Average target
$40.00
High target
$40.00

Event Read

Catalysts should explain what can change the setup, when it might happen, and which AIQ component would move first.

Current event setup

Event date

Upcoming earnings date not available yet.

Sentiment score

News pressure around the setup.

Momentum score

Where event reaction would show up first.

AIQ score50/100

Composite decision read before event confirmation.

Analyst context

Consensus
Buy
Analysts
1
Average target
$40.00
Target range
$40.00 - $40.00
90-day revisions
0

News And Sentiment

Recent company coverage, scored where source sentiment is available.

Positive
1
Neutral
0
Negative
0
finance.yahoo.com · Aug 9, 2026

Global Medical REIT Q2 Earnings Call Highlights

Chiron Real Estate reported second-quarter results as it continues to reposition its portfolio toward senior housing and away from outpatient medical real estate, with management emphasizing capital recycling, leadership additions and a growing investment pipeline. Chief Executive Officer Mark Deck

Open full news and sentiment

GMRE Catalysts FAQ

What are the next catalysts for GMRE stock?

GMRE's next stock catalysts can include earnings, guidance, analyst ratings, price-target changes, estimate revisions, product updates, regulatory events, contracts, or sector developments. Use this page to connect those events with AIQ and market context.

What upcoming events could move GMRE stock?

Upcoming events that could move GMRE include earnings reports, management commentary, estimate changes, major news, and market-wide sector catalysts.

How could GMRE's next earnings report affect the stock?

GMRE's next earnings report could affect the stock by changing revenue expectations, EPS estimates, guidance, analyst ratings, price targets, estimate revisions, and momentum.

What could drive GMRE stock higher?

GMRE could move higher if earnings, guidance, demand trends, analyst expectations, or AIQ momentum improve relative to what the market already expects.

What events could hurt GMRE stock?

GMRE could be hurt by weaker guidance, negative estimate revisions, margin pressure, adverse news, regulatory issues, or a sector-wide risk-off move.